Literature DB >> 15945060

Enhanced dopamine uptake in the striatum following repeated restraint stress.

Benjamin J Copeland1, Norton H Neff, Maria Hadjiconstantinou.   

Abstract

In mice administered chronic stress--repeated overnight restraint stress for 7 days--there was a prolonged enhancement of dopamine (DA) uptake into synaptosomes. The mRNA for the DA transporter (DAT) was found to be concomitantly increased in the midbrain, as was the binding of the transporter ligand mazindol to DAT in the nucleus accumbens and caudate-putamen. Kinetic analysis showed an increase in Vmax for DA, with little change in Km. No changes in tyrosine hydroxylase activity and tissue DA or 3,4-dihydroxyphenylacetic acid (DOPAC) content were observed. However, homovanillic acid (HVA) was found to be increased in the striatum of the stressed animals. Enhanced DAT activity attributable to chronic stress was still observed in animals treated with the DA D2 receptor antagonist haloperidol or the glucocorticoid receptor antagonist mifepristone. Modulation of DAT activity may be a physiological mechanism for regulating the concentration of DA that reaches receptors, following periods of stress.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15945060     DOI: 10.1002/syn.20169

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  16 in total

1.  Differential regulation of accumbal dopamine transmission in rats following cocaine, heroin and speedball self-administration.

Authors:  Lindsey P Pattison; Scot McIntosh; Evgeny A Budygin; Scott E Hemby
Journal:  J Neurochem       Date:  2012-05-23       Impact factor: 5.372

2.  Role of leaky neuronal ryanodine receptors in stress-induced cognitive dysfunction.

Authors:  Xiaoping Liu; Matthew J Betzenhauser; Steve Reiken; Albano C Meli; Wenjun Xie; Bi-Xing Chen; Ottavio Arancio; Andrew R Marks
Journal:  Cell       Date:  2012-08-31       Impact factor: 41.582

3.  Sleep deprivation differentially affects dopamine receptor subtypes in mouse striatum.

Authors:  Miranda M Lim; Jinbin Xu; David M Holtzman; Robert H Mach
Journal:  Neuroreport       Date:  2011-07-13       Impact factor: 1.837

4.  Early-Life Social Isolation Stress Increases Kappa Opioid Receptor Responsiveness and Downregulates the Dopamine System.

Authors:  Anushree N Karkhanis; Jamie H Rose; Jeffrey L Weiner; Sara R Jones
Journal:  Neuropsychopharmacology       Date:  2016-02-10       Impact factor: 7.853

5.  Differential effects of acute and repeated stress on hippocampus and amygdala inputs to the nucleus accumbens shell.

Authors:  Kathryn M Gill; Anthony A Grace
Journal:  Int J Neuropsychopharmacol       Date:  2013-06-10       Impact factor: 5.176

Review 6.  Stress responses and the mesolimbic dopamine system: social contexts and sex differences.

Authors:  Brian C Trainor
Journal:  Horm Behav       Date:  2011-08-31       Impact factor: 3.587

7.  Effects of immobilization stress on neurochemical markers in the motivational system of the male rat.

Authors:  Louis R Lucas; Ching-Jung Wang; Trudy J McCall; Bruce S McEwen
Journal:  Brain Res       Date:  2007-04-27       Impact factor: 3.252

8.  Feeding conditions differentially affect the neurochemical and behavioral effects of dopaminergic drugs in male rats.

Authors:  Rajkumar J Sevak; Wouter Koek; William Anthony Owens; Aurelio Galli; Lynette C Daws; Charles P France
Journal:  Eur J Pharmacol       Date:  2008-07-10       Impact factor: 4.432

9.  Orbitofrontal dopamine depletion upregulates caudate dopamine and alters behavior via changes in reinforcement sensitivity.

Authors:  H F Clarke; R N Cardinal; R Rygula; Y T Hong; T D Fryer; S J Sawiak; V Ferrari; G Cockcroft; F I Aigbirhio; T W Robbins; A C Roberts
Journal:  J Neurosci       Date:  2014-05-28       Impact factor: 6.167

10.  Neurotoxic effects of chronic restraint stress in the striatum of methamphetamine-exposed rats.

Authors:  M S Quinton; B K Yamamoto
Journal:  Psychopharmacology (Berl)       Date:  2007-04-26       Impact factor: 4.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.